Patent ID: 7402312

Claim:
A pharmaceutical composition comprising: (a) a first antibody that specifically binds a VEGF-2 polypeptide, said antibody comprising an amino acid sequence that is at least 95% identical to an amino acid sequence selected from the group consisting of: (i) the amino acid sequence of the VH domain of the antibody expressed by the hybridoma cell line deposited under ATCC™ Deposit No. PTA-3341 or PTA-3342; (ii) the amino acid sequence of the VL domain of the antibody expressed by the hybridoma cell line deposited under ATCC™ Deposit No. PTA-3341 or PTA-3342; (iii) both (i) and (ii); (iv) the amino acid sequence of the VH domain of SEQ ID NO:76 or 78; (v) the amino acid sequence of the VL domain of SEQ ID NO:77 or 79; and (vi) both (iv) and (v); and (b) a pharmaceutically acceptable carrier.